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Primary keratinocytes immortalized by human papillomaviruses (HPVs), along with HPV-induced cervical
carcinoma cell lines, are excellent models for investigating neoplastic progression to cancer. By simultaneously
visualizing viral DNA and nascent viral transcripts in interphase nuclei, we demonstrated for the first time a
selection for a single dominant papillomavirus transcription center or domain (PVTD) independent of inte-
grated viral DNA copy numbers or loci. The PVTD did not associate with several known subnuclear addresses
but was almost always perinucleolar. Silent copies of the viral genome were activated by growth in the DNA
methylation inhibitor 5-azacytidine. HPV-immortalized keratinocytes supertransduced with HPV oncogenes
and selected for marker gene coexpression underwent crisis, and the surviving cells transcribed only the newly
introduced genes. Thus, transcriptional selection in response to environmental changes is a dynamic process
to achieve optimal gene expression for cell survival. This phenomenon may be critical in clonal selection during
carcinogenesis. Examination of HPV-associated cancers supports this hypothesis.
Cellular responses to growth stimuli or stress quickly result
in adaptive chromatin remodeling, leading to alterations in
gene expression. Modulations made to optimize cell survival
can result in the dysregulation of genes governing cell growth
and differentiation and in genomic instability (28), such as
those associated with neoplastic progression. In cancers in
which cellular proto-oncogene amplification has occurred,
higher than normal levels of proto-oncoprotein are observed.
Whether this is a result of transcription from all amplified gene
copies or from a single locus with increased promoter strength
or, alternatively, of mRNA stabilization remains to be eluci-
dated. A superb system for studying genetic and transcriptional
alternations associated with neoplastic progression can be
found in early and late passages of primary keratinocytes im-
mortalized by high-risk human papillomavirus (HPV) geno-
types, in HPV-induced cervical cancers, and in cell lines de-
rived therefrom (73). In such cells, substantial changes have
occurred in cellular and viral gene expression relative to that in
productively infected, benign condylomata and papillomas. In
the present study, we used in situ analytic methods to visualize
HPV oncogene expression in individual cells of both experi-
mental model and naturally arising neoplasms and observed
striking and unexpected changes accompanying progression.
The molecular basis for HPV oncogenesis is predicated on
the mechanisms by which these normally benign viruses repro-
duce themselves. In productive infections, the 8-kb, double-
stranded, circular viral DNAs amplify as extrachromosomal
nuclear plasmids, and this amplification is restricted to post-
mitotic differentiated cells of the squamous epithelium. DNA
synthesis requires the E2 origin recognition protein and the E1
viral helicase protein, as well as the reactivated host replication
machinery. Thus, HPVs encode E6 and E7 oncoproteins that
bind to and inactivate the tumor suppressor proteins p53 and
the retinoblastoma family of tumor suppressor proteins, re-
spectively, to bypass cell cycle controls (37, 38). Typically, there
is little or no viral E6 or E7 oncoprotein gene expression in
basal cells due to negative controls exerted on the enhancer-
promoter by cellular factors and possibly by the viral E2 pro-
tein, which is also a transcription factor (10). As with cellular
genes (27), chromatin remodeling by posttranslational modifi-
cations of histones has also been implicated in viral gene reg-
ulation (15, 72).
In contrast to the noncycling, differentiated keratinocytes
comprising the suprabasal strata of benign productive HPV
lesions, much or all of the epithelium in high-grade dysplasias
and carcinomas consists of basal cell-like proliferating cells in
which viral DNA is often integrated and viral E6 and E7
oncogenes are invariably highly expressed (60, 73). These neo-
plastic changes are probably brought about by inopportune
and prolonged expression of the oncogenic HPV E6 and E7
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proteins in the normally rather quiescent reserve or stem cells
of the epithelia during repeated wounding and healing (10).
Consequently, excessive cell proliferation, accumulation of
mutations in key host regulatory genes, and chromosome in-
stability occur in these cells (37, 38). Cell lines such as SiHa,
CaSki, and HeLa were established from HPV-induced cervical
cancers, and they contain integrated HPV DNA from which
the continuous expression of the viral oncogenes is critical for
the maintenance of cell growth and the transformed pheno-
types (3, 14, 33, 41, 48, 50, 67, 70).
Viral DNA integration invariably occurs downstream of the
E6/E7 genes, often in the E1 or E2 gene region accompanied
by a deletion of downstream sequences, resulting in a loss of
feedback control of oncogene expression by the E2 protein.
Moreover, transcripts of the E6/E7 genes capture 3 cellular
untranslated sequences and polyadenylation signals (26, 48, 53,
68), and these fusion transcripts are more stable than those
derived from extrachromosomal viral DNA. This increase in
viral mRNA stability and the resulting elevated levels of viral
oncoproteins are considered to be important factors in neo-
plastic progression (23).
HPV-16 and HPV-18 oncogenes can immortalize primary
human keratinocytes in vitro (73). The immortal cells contain
multiple integrated HPV DNA, express telomerase and are
often hyperdiploid, with a gain or loss of partial or entire
chromosomes (36, 54, 57, 59). Early-passage immortal cells are
typically not tumorigenic in nude mice, whereas cells at higher
passages exhibit more dysplastic histology when grown as or-
ganotypic raft cultures, simulating the histopathological char-
acteristics of low-, moderate-, and high-grade dysplasias (21,
58). Eventually, tumorigenic clones may emerge after long-
term culturing, presumably due to additional mutations in cel-
lular genes incurred during passage (73). Along with cervical
carcinoma cell lines, these immortalized cells serve as experi-
mental models with which to investigate chromosomal changes
that occur in patient lesions during the progression to dyspla-
sias and cancers. However, the regulation of viral transcription
in these immortalized cells or cancers had not been examined
in detail.
In the present study, we used in situ hybridization in con-
junction with tyramide-fluorescence enhanced signal deposi-
tion (T-FISH) (1, 4, 65) to visualize viral RNA transcription
foci in HPV DNA-immortalized human keratinocytes. We also
identified chromosomes that harbored active centers in CaSki
and SiHa cells by simultaneous detection of nascent viral
RNA, integrated viral DNA, or chromosomal territories. Both
CaSki and SiHa cells are hyperdiploid. CaSki cells harbor ca.
600 copies of HPV-16 DNA distributed over 11 or more chro-
mosomal sites, mainly in tandem arrays. The complex chromo-
somal rearrangements and the large number of sites of inte-
gration have up till now prevented cytogenetic mapping of the
integrated viral DNAs. SiHa cells, in contrast, possess only two
copies of HPV DNA, one each in the two copies of chromo-
some 13 at locus 13q21 (1, 3, 17, 33). Our results demonstrate
that, regardless of the copy number of integrated viral DNA or
number of distinct integration sites, natural selection favors
cells containing only one or at most two transcriptionally active
viral DNA center(s), which was preferentially localized to the
perinucleolar region. All other integrated viral DNA copies
become transcriptionally inactive. This perinucleolar domain,
designated the papillomavirus transcriptional domain (PVTD),
is distinct from other major nuclear domains commonly stud-
ied. Some of the silent copies can be reactivated by growth for
one to two cell divisions in medium containing 5-azacytidine,
implicating DNA methylation in the silencing. Conversely, the
active copy can be silenced under challenge for cell survival. Of
particular medical relevance, examination of HPV-associated
primary cancers also revealed one nascent viral transcription
center per cell. Collectively, these observations indicate that
the selection for the fittest cells via transcriptional silencing is
a dynamic and reversible process. The implications of this
process of transcriptional modulation during oncogenesis are
discussed.
MATERIALS AND METHODS
Cell and organotypic cultures. CaSki and SiHa cells were obtained from the
American Type Culture Collection (ATCC; Manassas, Va.) and were cultured in
Dulbecco modified Eagle medium with 10% fetal bovine serum at 37°C in 5%
CO2. All immortalized keratinocyte cell lines were passaged in keratinocyte-
specific SFM (Invitrogen, Carlsbad, Calif.). Raft cultures were prepared as de-
scribed previously (8, 40).
Nucleic acid hybridization probes and probe labeling. HPV genomic DNA
probes for in situ hybridization were prepared by nick translation of genomic
plasmid DNAs in the presence of biotinylated dUTP. The probes were precip-
itated in the presence of 0.4 g of Cot-1 DNA, 0.20 g of yeast tRNA, and 0.6
g of salmon sperm DNA/l. The probe cocktail was prepared in Hybridsol VII
(Ventana Medical Systems, Tucson, Ariz.) as described previously (65). HPV
genomic DNA probes for Southern and Northern blot hybridization were pre-
pared by nick translation in the presence of [-32P]dCTP (Perkin-Elmer Life
Sciences, Boston, Mass.).
In situ detection of nascent viral transcripts, viral DNA, chromosomal DNA,
or protein. Simultaneous detection of nascent viral RNAs and viral DNA or
chromosomal domains was performed essentially as described previously (24, 35,
69), with modifications pertaining to the use of tyramide signal amplification (4).
Hybridization to nascent RNA transcripts was performed without prior denatur-
ation of nucleic acids. Briefly, cells were permeabilized in CSK solution (19)
containing 0.5% Triton X-100 detergent for 3 min at 4°C, fixed with 4% para-
formaldehyde–1 mM MgCl2 (pH 7.2) for 10 min, dehydrated in ethanol, and
hybridized with probes. After overnight incubation with probes in Hybrizol VII
at 37°C, slides were washed extensively and then incubated with a 1:100 dilution
of streptavidin-horseradish peroxidase (HRP) conjugate in 4 SSC (1 SSC is
0.15 M NaCl plus 0.015 M sodium citrate) at 37°C for 1 h. After a washing step,
signals were revealed with a tyramide-fluorophor (1:100 dilution in Amplification
Diluent; Perkin-Elmer). First-round HRPs were inactivated by 3% hydrogen
peroxide in 4 SSC at room temperature prior to further probing.
To detect viral DNA or for interphase chromosome paints, slides were treated
with 100 g of RNase A (Sigma)/ml in 2 SSC at 37°C, dehydrated in ethanol,
denatured in 70% formamide–2 SSC (pH 7.0) at 72°C, dehydrated in ethanol,
and hybridized with probes. After overnight incubation at 37°C, slides were
treated as described for nascent RNA detection. For simultaneous detection of
viral DNA and chromosome paints, viral DNA was probed first. Direct fluores-
cein isothiocyanate (FITC)-conjugated chromosomal paints from Vysis (Down-
ers Grove, Ill.) were detected by using the manufacturer’s protocol. Digoxigenin
paint probes from Oncor (Gaithersburg, Md.) were detected by using either an
anti-digoxigenin (DIG)-FITC or an anti-DIG-Texas red antibody (Roche, Indi-
anapolis, Ind.). Cells were stained with DAPI (4,6-diamidino-2-phenylindole;
Sigma) at 0.05 mg/ml and mounted in Antifade.
Antibodies used in the present study were: SC35 (Sigma, St. Louis, Mo.); PML
(PG-M3), C23 (MS-3; Santa Cruz Biotechnology, Santa Cruz, Calif.), and
p220npat (a gift from J. Wade Harper) (31). For C23 antigen detection (Sigma),
slides were incubated with a 1:100 dilution of primary antibody in 50% goat
serum, 1 phosphate-buffered saline at 37°C, washed, and then incubated again
with a 1:100 dilution of a goat anti-mouse-TRITC (tetramethyl rhodamine iso-
thiocyanate) antibody. For the other antigens, Antigen Retrieval (Dako, Carpin-
teria, Calif.) was performed prior to probing with 1:100 dilution of primary
antibodies. After a washing step, a secondary goat anti-rabbit or anti-mouse-
HRP antibody was then applied for 1 h at 37°C (Roche). The slides were washed,
developed by using a 1:100 dilution of fluorescence-tyramide (Perkin-Elmer),
stained with DAPI, and mounted with Antifade.
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HPV typing of paraffin-embedded patient biopsy specimens was conducted on
DNA recovered from tissue sections by using nested PCR amplification, followed
by diagnostic restriction enzyme digestions. After deparaffinization, 4-m sec-
tions were treated with a proteinase K solution (Dako) for 6 min, ethanol
dehydrated, and probed for viral RNA and then reprobed for viral DNA with
nick-translated probes.
Southern blot analysis, Northern blot analysis, and 3 RACE. A total of 7 g
of total cellular DNA from FK16A and FK18B cells at different passages were
digested with PstI and separated in a 0.8% agarose gel. Southern blot hybrid-
ization was performed with 32P-labeled HPV-16 genomic DNA probes. For
Northern blot analysis, total RNA was isolated by using TRIzol reagent (Invitro-
gen) from cell lines. Total RNA were also isolated from CaSki cells with or
without prior treatment with 10 M 5-azacytidine (Sigma) at 37°C for 40 to 48 h.
RNA was digested with RNase-free DNase I before being separated in a 1%
formaldehyde gel, transferred to nitrocellulose membranes, and probed. The
blots were analyzed with a Molecular Dynamics PhosphorImager. 3 RACE
(rapid amplification of cDNA ends) analysis of HPV RNAs from CaSki cells was
performed as described previously (68). Five cDNA clones were randomly se-
lected and sequenced by the UAB Sequencing Core Facility.
Lentiviral vectors and transduction. An human immunodeficiency virus
(HIV)-based vector was used to introduce genes expressing either enhanced
green fluorescent protein (GFP)-internal ribosome entry site (IRES)-puro or
HPV-18 E6/E7-IRES-puro into the FK18B cell line. The vector was similar to
that described (7, 66). The eGFP or E6/E7 coding sequence was inserted 5 of
the IRES, and each was under control of the early cytomegalovirus promoter.
Infectious stocks of vectors were prepared by transfection of 293T cells as
described previously (39) and used at a multiplicity of infection of 1 or 10 to
transduce FK18B cells at passage 109.
Light microscopy. Slides were viewed with an Olympus AX70 microscope
equipped with a Speicher Filter Set (ChromaTechnologies, Brattleboro, Vt.).
Photographs were taken by using a Zeiss Axiocam and Zeiss software. Quanti-
fication was conducted on at least 200 cells per event.
RESULTS
Detection of HPV DNA by T-FISH. We first determined the
sensitivity, specificity and resolution of tyramide-fluorescence
in situ hybridization (T-FISH) for viral DNA localization in
permeabilized intact interphase cells. Using genomic viral
DNA probes, we routinely observed two small signal centers in
SiHa cells (Fig. 1A, Cy3, red). In CaSki cells, we detected
multiple foci distributed into many distinct big or small centers
(Fig. 1E, Cy3, red). We surmise that hybridization signal size
and intensity of deposited labeled tyramide reflect viral DNA
copy number, with the most intense signals marking the longest
viral DNA tandem arrays. Because the signal amplification is
an enzyme-driven reaction, a locus with a high-copy-number
target generates a diffuse signal that is spatially larger than the
actual target size (4).
Coincidence of nascent transcription centers with both HPV
DNA loci in SiHa cells. To determine whether both copies of
HPV-16 DNA in SiHa cells are transcriptionally active, we
probed for nascent viral RNA. Nuclear and cytoplasmic tran-
scripts that were released from the templates were removed as
described in Materials and Methods. Nascent HPV-16 nuclear
RNAs were first revealed with a biotinylated nick translated
DNA probe (Fig. 1B, FITC, green). After RNase treatment
and denaturation, viral DNA was again hybridized with a bio-
tinylated DNA probe, which was then revealed with a different
fluor-conjugated tyramide (Fig. 1C, Cy3, red). Two nascent
viral RNA transcript foci were visualized, overlapping the viral
DNA signals. The cell illustrated in Fig. 1B and C was in late
S or G2 phase, since paired signals from one of the two pairs of
sister chromatids were clearly visible, whereas the other pair
could have been oriented in such a way (above and below one
another) that the signals appeared as one. As controls, the
nascent RNA foci were RNase sensitive. Using a riboprobe
specific for E6 and E7, we demonstrated that both centers are
FIG. 1. Detection of viral DNA and nascent transcription centers in CaSki and SiHa cervical cancer cell lines. (A and E) Detection of HPV-16
DNA (Cy3; red) in SiHa cells (A) or CaSki cells (E) with nick-translated probes in permeabilized interphase cells. (B and C) Simultaneous in situ
detection in a single interphase SiHa cell of nascent HPV-16 RNA (FITC) (B) and HPV-16 DNA (Cy3) (C) by sequential hybridization with a
nick-translated genomic probe. (D) Interphase chromosome analysis of SiHa cells for nascent HPV transcripts (FITC) and the chromosome 13
territory (Cy3). (F to H) Simultaneous in situ detection in a single interphase CaSki cell of nascent HPV-16 RNA (FITC) (F) and viral DNA (Cy3)
(G) by sequential hybridization with a nick-translated genomic probe. (H) Merged image of panels F and G. Images were captured with a 40
(A and E) or 100 (B to D and F to H) objective lens but enlarged to different extent to display several cells (A and E) to show reproducibility
or for a single cell for clarity (B to D and F to H). In all panels, nuclear DNA was stained with DAPI (blue).
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producing E6 and E7 transcripts (data not shown). In another
control, viral DNA was not detected when cells were not
treated with denaturing conditions (data not shown). Rarely
did we observe additional nuclear or cytoplasmic viral RNA.
Probing with a nick-translated biotinylated probe specific for
HIV contained in a plasmid of similar backbone and size dem-
onstrated no detectable signal (data not shown). Collectively,
these results confirm that the signals were indeed nascent tran-
scripts. Finally, we probed for nascent viral RNA and for
chromosome 13 with specific paints in interphase cells. Both
viral transcription centers (Fig. 1D, green) were observed to
associate spatially with chromosome 13 territories (Fig. 1D,
red). These results agree with the previous report that SiHa
contains two partially deleted, integrated HPV-16 genomes at
genetically similar if not identical loci on chromosome 13 (1, 3,
17, 33). We now demonstrate that both copies are transcrip-
tionally active.
One nascent HPV transcription center in CaSki cells. DNA
probes were used to detect transcriptional centers in CaSki
cells. Unexpectedly, of the several hundred copies of inte-
grated viral DNA, only a single nuclear RNA hybridization
signal was typically observed (Fig. 1F, green). This center con-
sistently colocalized with a low-intensity viral DNA focus (Fig.
1G, red) but not with the much larger tandem arrays of viral
DNA. A merged image is shown in Fig. 1H. This nascent RNA
center was RNase sensitive and was not observed with HIV
probes (data not shown).
Identification of small viral integration centers in the CaSki
cells. To determine whether the single transcriptionally active,
small DNA center in CaSki cells was clonal, or one that dif-
fered among individual cells, we proceeded to identify chro-
mosomes that harbor low copy numbers of HPV DNA by using
T-FISH on metaphase chromosomes. We found that CaSki
cells contained between 75 and 78 chromosomes, and we de-
tected between 12 and 16 distinct integration sites (Fig. 2A,
red). On the basis of their fluorescence probe signals, most loci
contained multiple copies of viral DNA, and only three chro-
mosomes contained a low copy number of viral DNA.
Sequential hybridization for HPV-16 DNA (in red) and then
with individual chromosome paints (in green) on metaphase
FIG. 2. Mapping of the HPV transcription center in CaSki cells. (A) In situ hybridization to detect integrated HPV DNA (Cy3) in metaphase
chromosomes (DAPI) in a CaSki cell. (B and C) Localization of HPV-16 DNA in CaSki cells by dual hybridization with a HPV-16 DNA probe
(Cy3) and individual chromosome paints (FITC) on metaphase chromosome spreads (DAPI). A high-copy-number of HPV-16 DNA was found
on two of the four major chromosomes 2 (green chromosomes with a yellowish arm in panel B). Chromosome 9 harbors no HPV DNA (C).
(D) One or a few copies of HPV-16 DNA (FITC) were found on one of three acrocentric chromosomes 14 (Cy3). The paint did not color the entire
metaphase chromosome (DAPI). (E to I) Interphase chromosome analysis of CaSki cells for nascent HPV transcription (Cy3) and chromosomal
territory domains (FITC) showing chromosome 14 (E), chromosome X (F), chromosome 13 (G), chromosome 6 (H), and chromosome 22 (I). All
images were captured with a 100 objective lens but were enlarged to different extents for clarity.
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chromosomes revealed that chromosome 2 or chromosome 2
derivatives (Fig. 2B) contained a high HPV copy number,
whereas chromosome 9 (Fig. 2C) and chromosome 13 (data
not shown) are devoid of integrated HPV. Low-copy HPV
integration was observed for chromosomes 3 and 14 and an
unidentified marker chromosome that resembles chromosome
21 or 22 by DAPI banding (data not shown).
Localization of a clonal transcription center to a derivative
chromosome 14 in CaSki cells. To identify the chromosome
that harbored the transcriptionally active HPV DNA in CaSki
cells, we simultaneously probed for nascent HPV-16 RNA (in
red) and for one of several individual chromosome territory
domains (in green) in interphase cells. Visual inspection of the
spatial localization of viral RNA center revealed a 70% asso-
ciation with chromosome 14 (Fig. 2E) and a statistically insig-
nificant (15%) association with chromosomes 3 or 21 (data
not shown). Because our 3 RACE analysis suggested a link to
chromosome 6 or 22 (see below), we also examined these
chromosomal territory domains. Analysis of interphase cells
showed a 91% association with chromosome 6 (Fig. 2H) but no
significant association with chromosome 22 (Fig. 2I). Indeed,
by metaphase chromosome painting, one derivative chromo-
some 14 was observed to harbor a low copy of HPV integrant
(Fig. 2D, in green). The chromosome 14 paint (Fig. 2D, in red)
did not hybridize to a small region that was proximal to the
HPV DNA but distal to the centromere. Collectively, these
results suggest that a clonal selection occurred for a transcrip-
tionally active HPV DNA located on a derivative chromosome
14, which may contain some translocated chromosome 6 ma-
terials. However, metaphase paint analysis failed to demon-
strate chromosome 6 sequences proximal to the HPV genome
(data not shown). Thus, this locus may have a complex chro-
mosomal rearrangement. As controls for specificity, nascent
HPV RNA did not associate with large tandem HPV DNA
repeats on chromosome 2, nor with chromosomes such as X or
13 (15% association) that had no integrated HPV (Fig. 2F
and G).
Clonal RNA transcription in CaSki cells by 3 RACE. To
substantiate a clonal selection for the viral transcription center,
we performed a 3 RACE experiment to determine the virus-
host RNA junction sequences. Sequence analysis of five inde-
pendent cDNA clones placed the 3 viral-cellular junction at
HPV-16 nucleotide position 3728 in the overlapping E2/E4
open reading frames. All five cDNAs had the same cellular
sequence of 98 or 99 bases, followed by the posttranscription-
ally added poly(A), in agreement with previous reports (3, 52,
68). Thus, we are indeed dealing with the same CaSki cells as
in previous reports. Interestingly, our cDNAs contained alter-
native E1∧E4 mRNA splices that differ in the acceptor site at
either nucleotide 3357 (two cDNAs) or, one codon later, nu-
cleotide 3360 (three cDNAs). Alternative splicing of this mes-
sage was not reported previously but was predicted based on
comparative sequence analysis (11). BLASTN analysis of the
host sequence revealed a homology or identity with sequences
that are associated with L2 line elements and a possible match
with sequences on chromosomes 6 and 22. The former, but not
the latter, is consistent with the chromosome paint analyses.
Taken together, these results support the conclusion that a
single active HPV center is in direct association with DNA
from chromosome 6 located on a derivative chromosome 14.
Selection for a single transcriptional center during passage
of HPV-immortalized keratinocytes. To test whether a single
transcription center observed in CaSki cells is a unique case or
is a common and reproducible event, we examined four pre-
viously well characterized primary human foreskin keratino-
cyte lines immortalized by either HPV-16 (FK16A, FK16B) or
HPV-18 (FK18A, FK18B) (57, 58, 59). The FK16A cell line
contains ca. 5 to 10 integrated copies of HPV DNA, whereas
FK16B contains more than 100 integrated copies. The FK18A
and FK18B lines both contain more than 100 copies of viral
DNA, but the two lines might be of clonal origin based on
Southern blot hybridization (59). These cell lines went from a
normal karyotype to a tetraploid state accompanied by various
chromosomal changes. In organotypic cultures, they exhibited
progressively more dysplastic phenotypes with increasing pas-
sage numbers (58).
At least 200 interphase cells each of FK16A, FK16B,
FK18A, and FK18B at different passages were analyzed for
their nascent viral RNA centers. The FK16A cell line demon-
strated up to five centers at passage 23, but at passages 64 and
82 there was only a single transcription center (Fig. 3A and B,
in green, and data not shown). The FK16B cell line at passage
27 had an average of 3.1 RNA centers per cell, but some cells
had as many as 7 centers. At passage 64, the average number
of transcription centers per cell had dropped to 2.3. At passage
92, the percentage of cells containing one center increased to
70%, whereas most of the remaining population contained two
centers (Fig. 3C and D, in green, and data not shown). Thus,
there appears to be a distinct trend toward selection for one
transcription center during passage of HPV-16 immortalized
cells. In FK18A and FK18B cells, only a single HPV transcrip-
tion center was observed, even at early passage, and this pat-
tern was maintained at later passages (Fig. 3E to F, in green,
and data not shown). Interphase viral DNA analysis of FK18A
and FK18B showed that both possessed a single viral DNA
integration focus. In these cell lines, the focus of viral RNA
transcripts (green) was always positioned at one end of the
larger DNA center (red) (Fig. 3G). Enlarged images of two of
the three cells in Fig. 3G are shown in Fig. 3H and I. We
suggest that that this pattern is consistent with transcription of
a DNA template located near or at the 3 end of the viral DNA
array, allowing the use of a downstream host cleavage site and
poly(A) signal, as in the cases of the CaSki and SiHa cell lines.
Had the entire array been actively transcribed, the RNA sig-
nals would have colocalized with the larger DNA signal (see
Fig. 7D and E). Collectively, our results strongly suggest that
cells with a single transcription center may have a distinct
growth advantage over cells with multiple RNA centers.
Changes in viral RNA expression but not viral DNA inte-
gration during passage. To determine whether a subpopula-
tion of genetically distinct cells was selected during passage
leading to the changing transcription, we performed Southern
blot hybridization analyses on these cell lines at different pas-
sage numbers. In FK16A, we observed two new minor DNA
bands in later passages (Fig. 4A), but no changes were ob-
served in FK16B (Fig. 4C) or FK18 cells (59) by Southern blot
analyses. Northern blot analysis of total RNA extracted from
early and late passages of the FK16A (Fig. 4B) and FK16B
(Fig. 4D) were also performed. In the FK16A cell line (Fig.
4B), there was a loss of a high-molecular-weight band in pas-
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FIG. 3. Localization and number of transcriptionally active HPV centers in immortalized human foreskin keratinocytes. (A to F) HPV RNA
centers (FITC, green) during passage relative to nucleoli, which was revealed by antibody to nucleolin or C23 (TRITC, red). Nascent viral RNAs
were detected by in situ hybridization with DNA probes in FK16A at passages 23 and 82 (A and B), FK16B at passages 27 and 92 (C and D),
FK18A at passages 23 and 114 (E and F), or FK18B at passage 115 (G, H, and I). Nuclear DNA was stained with DAPI. (G to I) Localization
of HPV RNA center (FITC) relative to HPV DNA in the FK18B. (H and I) Enlargement of two of the three cells in panel G (boxes). All images
were acquired with a 100 objective lens but were enlarged in panels H and I.
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sage 88 relative to passage 25 as the number of centers per cell
goes on average from 3 to 1. A more significant change in band
pattern and a reduction of intensity were seen in viral RNAs
from the late passage FK16B cell line (Fig. 4B), relative to
early-passage cells that exhibited up to seven centers per cell.
These results suggest epigenetic changes of the integrated viral
genes during passage could be responsible for silencing all but
one or two transcription centers.
Silencing of the original active center upon selection for
newly introduced HPV oncogenes. To test whether the reduc-
tion in transcription centers resulted from an active selection
against transcription from multiple centers, FK18B cells were
transduced with pseudotyped, recombinant HIV viruses that
expressed either HPV-18 E6 and E7 oncogenes or a green
fluorescent protein (GFP). The transgene was each placed
upstream of an IRES and a puromycin resistance gene (puro).
Each expression cassette was driven by the cytomegalovirus
immediate-early promoter. Passage 109 of FK18B cells that we
showed to harbor a single, established HPV RNA center was
infected with either recombinant virus at a multiplicity of in-
fection of 1 or 10 and selected with puromycin. During the
drug selection, mock-transduced cells all died, whereas cells
infected with the GFP-IRES-puro virus grew vigorously and
expressed GFP, a finding consistent with proviral DNA inte-
gration (Fig. 5A to C). In contrast, cells transduced with the
E6/E7-IRES-puro cassette developed many vacuoles and were
slow in growth, and many began to flatten out, which is remi-
niscent of senescence.
On cells that eventually grew out about 5 weeks after the
selection, we performed a nascent RNA assay for both puro
expression (in red) and for HPV-18 oncogene expression (in
green). Analysis of 200 GFP-expressing cells showed all to
contain one E6/E7 RNA center, in agreement with previous
observation. We found that 5, 82.5, and 11.5% of the cells,
respectively, had zero, one, and two puro RNA centers, and a
single cell had three centers. None of the puro RNA centers
colocalized with the HPV-18 RNA center (Fig. 5D to F), as
expected for undirected integration of the provirus. In con-
trast, in cells transduced with the HPV-18 E6/E7-IRES-puro
expression cassette, the HPV-18 RNA center invariably colo-
calized with the puromycin expression center (Fig. 5G to I).
Conversely, no puro center was distinct from the HPV-18
E6-E7 center. Among 200 transduced cells, 5% had no center,
whereas 93 and 1.5% had one and two dual-RNA centers, with
one cell having three such centers. These observations dem-
onstrate that a switch had occurred in the locus of viral onco-
gene expression from the original endogenous center to the
newly introduced center.
Single transcription centers in human cancer tissues. To
ascertain the biological relevance of the results obtained from
transformed and immortalized cell lines to HPV cancers, we
examined viral RNA transcription centers in formalin-fixed,
paraffin-embedded tissue biopsies of HPV-associated lesions.
To determine the feasibility of using these methods with par-
affin-embedded specimens, we first simultaneously detected
HPV RNA and DNA in 4-m sections of comparably fixed and
FIG. 4. Patterns of viral DNA integration and RNA expression in immortalized cell lines at different passages. (A) Southern blot analysis of
PstI-digested FK16A DNAs at passages 13, 23, 35, 94, and 105. (B) The right panel shows a Northern blot hybridization of FK16A RNAs at
passages 25 and 88, demonstrating a slight decline in expression. The left panel shows ethidium bromide staining of the 18S and 28S rRNA as a
loading control. (C) Southern blot analysis of PstI digestion of the FK16B cell line at passages 25 and 97. (D) The right panel shows a Northern
blot hybridization of FK16B RNAs at passages 25 and 97, demonstrating a large decrease in viral RNA expression. The left panel shows ethidium
bromide staining of the 18S and 28S rRNA as a loading control.
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paraffin-embedded organotypic raft cultures of FK16 and
FK18 lines. Nascent transcription centers were detected, and
the number of bright RNA foci in the nuclei correlated with
those present in cells grown in submerged cultures at similar
passage numbers. An example of a single DNA and RNA
center per cell in the FK18B cells at passage 118 is shown in
Fig. 6A. Some nuclei did not contain any RNA center, prob-
ably because the relevant portion of the nucleus was sectioned
off. In contrast, in productively infected laryngeal papillomas
that harbor a large number of extrachromosomal viral DNA,
abundant RNA was detected throughout the cells, as previ-
ously described (12, 61), masking all nascent transcription cen-
ters (Fig. 6B). Thus, a low transcriptional center number is a
prerequisite for center detection. These results also suggest a
high concentration of nascent viral RNA at the site of tran-
scription relative to low concentrations of completed and dis-
persed viral transcripts.
We then examined representative HPV-containing primary
cancers, including nine cases of HPV-16- or HPV-18-positive
squamous carcinomas of the cervix or vulva, three cases of
HPV-16-containing laryngeal or pharyngeal cancers, and 1
case of HPV-16-positive endocervical carcinoma. Strikingly, all
specimens exhibited a single viral RNA center per cell when
observable, regardless of the number of DNA foci. Figure 6C
demonstrates a typical pattern observed in 11 cases in which
only one small RNA center was associated with one of the
larger DNA centers. However, we cannot rule out that there
might have been a small number of additional centers present
at different focal planes or cut off in the thin tissue sections,
thus escaping detection. Two remaining cases harbored only a
FIG. 5. Expression of only the newly introduced viral oncogenes in FK18B cells under selection. Lentivirus vector transduction of a GFP-
IRES-puro center (A to F) or E6/E7-IRES-puro center (G to I) into FK18B cells at passage 109, followed by puromycin selection. (A) GFP-
positive cells (green); (B) DAPI-stained nuclei of the same cells as in panel A; (C) merged image of panels A and B; (D and E) detection of nascent
E6-E7 RNA (FITC) (D) and nascent RNA (E) of the puromycin resistance gene (Cy3) in interphase cells with DAPI-stained nuclei; (F) merged
image of panels D and E; (G and H) E6-E7 RNA center (FITC) (G) and nascent RNA (H) from the puromycin resistance gene (Cy3); (I) merged
image of panels G and H. Images were acquired with a 10 (A to C) or a 100 (D to I) objective lens.
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FIG. 6. Simultaneous probing for HPV RNA and DNA in formalin-fixed, paraffin-embedded tissue sections. We used 4-m sections. Left
panels, HPV RNA (FITC, green); middle panels, HPV DNA (Cy3, red); right panels, merged images of RNA and DNA signals. Nuclei were
stained with DAPI (blue). (A) Organotypic culture of FK18B passage 118 showing a single small viral RNA and a larger DNA center; (B) HPV-11
laryngeal papilloma; (C and D) representative specimens from 13 cases of cancers induced by HPV-16 or HPV-18 (not shown); (E) enlargement
of the boxed area in the right panel of specimen D. Images for A, C, and D were acquired with a 100 objective lens, and images for B were
acquired with a 40 objective lens.
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single HPV DNA locus that likely contained a tandem array
based on the size of the signal. In both cases, HPV RNA was
localized to the edge of the larger DNA signals, possibly sig-
nifying a transcriptionally active copy at the virus-host junction,
as in the FK18 cells described above. One example is shown in
Fig. 6D with an enlargement in Fig. 6E. These results support
our hypothesis that there is a selection for a single transcrip-
tion center during the development of HPV-induced cancers
and that, in cases with tandem arrays of integrated viral ge-
nomes, only the virus-host junction copy is transcriptionally
active.
Activation of transcription from silent viral DNA centers by
growth in 5-azacytidine. To begin to identify mechanisms by
which the majority of the integrated HPV DNA copies are
transcriptionally inactivated, we treated growing CaSki cells
for 40 to 48 h with 10 M 5-azacytidine, an inhibitor of DNA
methylation. Northern blot analysis of RNA revealed an in-
crease in the intensity of the existing messages and the appear-
ance of new transcripts in treated versus untreated cells (Fig.
7A). In situ hybridization revealed a number of large transcrip-
tion centers in treated cells (Fig. 7B, in red). However, activa-
tion was not observed in the majority of cells in these experi-
ments. This incomplete induction might be due to a cell cycle
effect, to an incomplete demethylation of the HPV DNA, or to
a toxic or lethal effect of the compound (25, 47). Indeed, we
observed a decreased cell number in treated cultures com-
pared to the untreated cultures, and cells with activated centers
were frequently rounded up. In contrast, treatment of cells
with trichostatin A, a potent inhibitor of histone deacetylases,
failed to activate the silenced centers (data not shown).
We also tested late passages of HPV-immortalized cell lines
that had only one nascent RNA center. In treated FK16A
passage 82 cells, multiple centers were observed (Fig. 7C, in
green). In treated FK18A passage 113 and FK18B passage 115
cells (Fig. 7D and E), the nascent HPV RNA signals (in green)
either colocalized with or were larger in size than the corre-
sponding DNA center (in red), a finding distinctively different
from the pattern in untreated cells (Fig. 3G to I). However, as
with CaSki cells, some treated cells contained only the original,
active 3 boundary copy (Fig. 7D). These observations suggest
that the long-term silencing of HPV DNA centers is mediated
at least in part by methylation on cytosine.
Perinucleolar localization of viral transcription. The nu-
cleus is a functionally organized environment, with many gene
expression and regulatory processes occurring in distinct sub-
nuclear domains (34, 35, 55). We investigated whether the
PVTD is spatially associated with previously described nuclear
domains that are known to be involved in transcription regu-
lation, RNA splicing, or cell cycle regulation, such as the nu-
clear domain 10 (ND10) or PML bodies (revealed by PML)
and Cajal bodies (20, 22, 46). Extrachromosomal HPV DNA
replication may occur in the neighborhood of ND10 (62), as is
the case with a number of other DNA viruses (18). Cajal
bodies (20) are nuclear domains implicated in the control of
S-phase-associated histone gene transcription mediated by
p220npat (31, 71).
Colocalization studies were performed first with CaSki cells
by probing for nascent HPV-16 transcripts (in red) and then
for PML (Fig. 8A, in green) or for p220npat (Fig. 8B, in green),
with or without an antigen retrieval process. We observed no
associations. Additional domains involved with gene transcrip-
tion and RNA metabolism are the interchromatin granule clus-
ters that are visualized as immunofluorescent “speckles” with
antibodies to spliceosome assembly factor SC-35 (56). Simul-
taneous visualization of SC-35 antibody (in green) and
HPV-16 DNA in CaSki cells (in red) (Fig. 8C) showed only
stochastic colocalization with the larger tandem viral DNA
arrays. Although most of the transcripts of oncogenic HPVs
spanning the E6 region are spliced, nascent viral RNA (Fig.
8D, in green) did not spatially associate with SC-35 domains
(red) (Fig. 8D). This lack of association has also been reported
for transcripts of some cellular genes as well (51).
Localization of nascent viral nuclear RNA (in green) to a
perinucleolar region was, however, consistently observed by
using an antibody to nucleolin (also called C23) (in red), a
marker for nucleoli (30) (Fig. 8E). About 75% of all detectable
HPV-16 transcription centers (in green) were perinucleolar
(within one to two viral RNA signal diameters from the nu-
cleolus), and another 12% appeared to overlap the nucleoli.
Signals that were at first thought to be away from nucleoli were
in fact associated with very small C23-positive dots when
viewed at high magnification. We then examined SiHa cells for
the association with C23, Cajal bodies, and SC35 domains.
Only localization to perinucleolar region was consistently
noted (Fig. 8F, Table 1, and data not shown). Similarly, nas-
cent viral transcripts in the immortalized cell lines were also
perinucleolar regardless of the number of transcription centers
in the cells (Fig. 3A to F in red, Table 1). At present, the
significance of this perinucleolar PVTD is not understood.
DISCUSSION
Previous studies of the HPV-16 and HPV-18 immortalized
and transformed cell lines provide strong support for the no-
tion that these cell lines are faithful experimental models with
which to investigate the genetic, epigenetic, and biochemical
changes that occur during the progression of dysplastic HPV
lesions to cancers. By virtue of the phenotypic inactivation of
the tumor suppressor proteins pRB and p53, the oncogenic
HPV E7 and E6 initiate a neoplastic process in the anogenital
TABLE 1. Localization of PVTD relative to the nucleolus in
HPV-immortalized and -transformed cell linesa
Cell line Passage no.
% of nucleolar association
Peri Direct None
FK16A 23 87.0 7.0 6.0
82 86.5 10.0 3.5
FK16B 27 78.5 8.0 13.5
64 78.5 14.0 7.5
FK18A 23 84.0 5.5 10.5
114 78.5 10.0 11.5
FK18B 17 88.5 4.5 7.0
115 87.5 6.0 6.5
CaSki NAb 75.0 12.0 13.0
SiHa NA 77.5 9.5 13.0
a Nascent HPV RNA signals were scored as perinucleolar (Peri) association
when they were located within two diameters of the RNA signals from the C23
(nucleolin) signals and as direct association when the two signals overlapped. A
total of 200 signals were counted from each culture.
b NA, not applicable.
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tract epithelium (37, 38, 73). Subsequent selection for and
accumulation of mutations in yet-to-be-identified key cellular
regulatory genes promotes further progression to cancer. In
the present study, by using these model systems along with
cancer tissues, we have uncovered an active and parallel epi-
genetic selection process for cells with certain striking charac-
teristics of viral oncogene transcription during progression.
Using T-FISH to probe for nascent viral RNA simulta-
FIG. 7. Transcriptional activation of silenced HPV DNA centers by 5-azacytidine. (A) The right panel shows a Northern blot hybridization of
HPV-16 RNA in CaSki cells with (lane) or without (lane) treatment with 10 M 5-azacytidine for 48 h. The left panel shows ethidium bromide
staining of the 18S and 28S rRNAs of the gel, demonstrating equal loading. (B) In situ detection of nascent HPV-16 RNA (Cy3) in CaSki cells
after 5-azacytidine treatment. Because of the high abundance of viral RNAs, some cytoplasmic mRNA was also detected by the probes despite in
situ extraction. (C) 5-Azacytidine-treated FK16A cells at passage 82. (D and E) Viral RNA (FITC) and DNA (Cy3) in FK18A cells at passage 113
(D) and in FK18B cells at passage 115 (E) upon treatment with 5-azacytidine. Nuclei were stained with DAPI. Note that nascent RNA (FITC)
completely overlaps the DNA signal in some of the cells (white dots). The images in panels B to E were acquired with a 100 objective lens but
are presented in different sizes for clarity and to reveal the reproducible patterns of expression among cells.
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neously with integrated viral DNA, metaphase or interphase
chromosomes, or nuclear domains with T-IF, we demonstrate
here for the first time directly that there is a strong selection
for cells containing only a single transcriptionally active viral
DNA integrant and that this locus is perinucleolar in the ma-
jority of the cells examined, regardless of the number of cen-
ters (Fig. 1, 3, 5, and 8). We have named this the PVTD.
Additional viral copies do not have associated nascent viral
RNA transcripts. The SiHa cell line appears to be an excep-
tion, since both copies of HPV-16, one each at genetically
identical loci on the pair of chromosomes 13 (1, 3, 17, 33), are
transcriptionally active (Fig. 1). We speculate that this double
RNA center might even have arisen as a result of positive
selection for a chromosome duplication or gene conversion
event. Oncoprotein production in their progenitor cells might
have been less than optimal and became outcompeted by cells
that underwent the duplication during the development of the
cancer or the establishment of the cell line. Similarly, cells that
no longer express viral oncogenes will not be maintained, as
clearly demonstrated by in vitro experimentation (14, 67).
Our data also indicate that, within any one cell line, the
single RNA center is clonal rather than stochastically variable
among individual cells, implicating a regulated expression.
First, our systematic in situ mapping data revealed that the
transcriptionally active template in CaSki cells is located at a
single-copy or low-copy-number site on a derivative chromo-
some 14 (Fig. 2), among the dozen loci that together harbor up
to 600 copies of viral DNA. These mapping data are supported
by 3 RACE in which five of five cDNAs have the same virus-
host junction sequence. Second, in FK18 cells harboring mul-
FIG. 8. Perinucleolar localization of PVTD. With the exception of nucleoli, no association was found between PVTD, as denoted by nascent
HPV RNA, and several nuclear domains, as specified. (A to E) CaSki cells; (F) SiHa cells. (A) ND10 domains detected with an antibody to PML
in green and viral RNA in red; (B) p220NPAT, a Cajal body-associated protein in green and viral RNA in red; (C) SC35 domain in green and
integrated HPV DNA in red; (D) SC35 domain in red and nascent HPV RNA in green; (E and F) antibody to C23 (nucleolin) in red and HPV
RNA in green. All images were captured at 100 magnification and are presented at a similar magnification except panel B, which is shown at
a lower magnification.
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tiple copies of the HPV-18 DNA in a single large tandem
array, only the virus-host junction copy appears to be tran-
scribed (Fig. 3). Of greatest relevance, each of 13 primary
HPV-associated cancers examined also exhibited one viral
transcription center per cell, when observable (Fig. 6).
Our data show that the evolving viral transcription patterns
are attributed to epigenetic rather than genetic alterations, in
that transcription from the inactive integrants can be reacti-
vated by 5-azacytidine, implicating DNA methylation as at
least being partially responsible for silencing transcription (Fig.
7). Reactivation was not achieved by exposing the cells to
trichostatin A, an inhibitor of histone deacetylases (data not
shown). These results agree with the current view that DNA
methylation confers long-term DNA silencing, whereas
deacetylases shut off transcription on a short-term basis (13,
43). Our observations are in excellent agreement with a recent
report (2) that HPV-16 DNA is targeted for CpG methylation
in vivo and that changing methylation patterns were observed
with different lesion grades. The data are also consistent with
reports that transfected and integrated HPV DNA is heavily
methylated and transcriptionally silent (5, 29, 45). However,
reactivation was not demonstrated in those studies.
Our findings explain why one predominant viral transcript
was identified in cancers and carcinoma cell lines (26, 53, 68)
and also why little or no E2 protein is expressed. We speculate
that transcription from the internal copies may have contrib-
uted relatively little to the expression of viral oncoproteins
relative to the junction copy due to low stability of mRNA
utilizing the viral poly(A) site (23). Furthermore, there is also
a selection against cells that express high levels of E2 which
would downregulate the promoter for the viral oncogenes (9,
14, 16, 44, 63, 67). An additional impetus for silencing comes
from our recent observation that the HPV E2 protein associ-
ates with the mitotic spindles to enable extrachromosomal
HPV DNA plasmids to segregate as minichromosomes and to
establish persistence (64). However, upon viral DNA integra-
tion, E2 might contribute to genomic instability if E2 bound to
the viral origin in tandemly integrated HPV DNA creates a
viro-centromere, causing chromosome breakage when it is
pulled to the opposite centrosome relative to the kinetochore.
Mitotic catastrophe associated with the breakage-fusion bridge
cycle (32) can be avoided only when the internal tandem viral
copies capable of encoding E2 are silenced. Selection for the
fittest cells for progression can then begin.
The selection for a single dominant expression locus appears
to be a dynamic and plastic process. Various immortalized cell
lineages reached this state after different numbers of cell divi-
sion during passage in vitro, perhaps depending on the number
of viral integration sites, the transcriptional activities from
these various loci, and the relative mRNA stabilities conferred
by the captured 3 host untranslated regions and poly(A) se-
quences. The selection may ultimately be predicated on the
absolute level of viral oncoprotein expression, as was suggested
by our oncogene challenge experiment (Fig. 5). By introducing
an extra copy of the HPV oncogenes into a cell line which had
already arrived at a single expression center, we presented a
striking example in which another round of transcription cen-
ter selection was attained within a matter of weeks when the
cells experienced a new and strong selection pressure for the
newly introduced viral oncogenes that are transcriptionally and
translationally coupled to a drug resistance gene. The surviving
cells that emerged from an apparent “crisis period” turned off
the original viral RNA expression center and replaced it with
the newly introduced copy, gaining puromycin resistance while
maintaining E6/E7 production. Thus, the crisis may have been
caused by too much of the viral oncoproteins. Had the higher
level of viral oncogene gene expression from both the resident
and the newly introduced copies been of no consequence or
even advantageous to the cells, we would not have observed
the silencing of the original viral RNA center. We presume
that the silencing of the original RNA center might be attrib-
uted to chromatin remodeling by DNA methylation, as was
observed in other cell lines. However, extensive cell death
upon exposure to 5-azacytidine prevented us from testing this
hypothesis.
Although the selection for cells with more stable transcripts
and higher levels of viral oncoproteins in proliferating cells is
important at the early stage of viral oncogenesis, in the long
run, what seems to be important is an optimal level of onco-
gene expression from a locus most suitable for the particular
environment in which the cells find themselves. Neither too
little nor too much of the viral oncoproteins will do. Cells that
fail to cycle rapidly are overgrown; those that divide too quickly
may not be able to replenish their cellular components and are
lost during passage, and others may undergo senescence. Our
results with primary HPV cancers are consistent with a clonal
selection for the fittest cells, which is in agreement with the
notion that cancer is monoclonal in origin (6, 28). We suggest
that the ability to detect a single viral RNA center might
provide for a novel, highly relevant biomarker of neoplastic
progression. Additional experiments will be required to test
this hypothesis. Cellular oncogenes are amplified in a variety of
cancers, e.g., the N-myc locus in neuroblastomas (49), ErbB2
in breast cancer, and EGRF in other cancers (42). It will be
most interesting to determine how many of the amplified cop-
ies are actively transcribed. Finally, the ability to conduct mul-
tiplex assays with tyramide-enhanced reagents and the gene
regulatory concepts described here will have considerable ap-
plicability to attempts at cancer control, analysis of diseases,
production of transgenic stem cells, and gene replacement
therapy.
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